Medivie Therapeutic Stock Total Asset
| MDVI Stock | ILA 80.40 0.20 0.25% |
Medivie Therapeutic fundamentals help investors to digest information that contributes to Medivie Therapeutic's financial success or failures. It also enables traders to predict the movement of Medivie Stock. The fundamental analysis module provides a way to measure Medivie Therapeutic's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medivie Therapeutic stock.
Medivie |
Medivie Therapeutic Company Total Asset Analysis
Medivie Therapeutic's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Medivie Therapeutic Total Asset | 12.19 M |
Most of Medivie Therapeutic's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medivie Therapeutic is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Based on the latest financial disclosure, Medivie Therapeutic has a Total Asset of 12.19 M. This is 99.84% lower than that of the Healthcare sector and 99.63% lower than that of the Medical Instruments & Supplies industry. The total asset for all Israel stocks is 99.96% higher than that of the company.
Medivie Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medivie Therapeutic's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medivie Therapeutic could also be used in its relative valuation, which is a method of valuing Medivie Therapeutic by comparing valuation metrics of similar companies.Medivie Therapeutic is currently under evaluation in total asset category among related companies.
Medivie Fundamentals
| Return On Equity | -1.56 | |||
| Return On Asset | -1.09 | |||
| Operating Margin | (24.81) % | |||
| Current Valuation | 47.6 M | |||
| Shares Outstanding | 2.88 M | |||
| Shares Owned By Insiders | 72.29 % | |||
| Price To Book | 10.59 X | |||
| Price To Sales | 71.11 X | |||
| Revenue | 491 K | |||
| Gross Profit | (603 K) | |||
| EBITDA | (5.16 M) | |||
| Net Income | (6.59 M) | |||
| Cash And Equivalents | 4.15 M | |||
| Cash Per Share | 1.44 X | |||
| Total Debt | 3.19 M | |||
| Debt To Equity | 0.85 % | |||
| Current Ratio | 0.65 X | |||
| Book Value Per Share | 1.32 X | |||
| Cash Flow From Operations | (3.88 M) | |||
| Earnings Per Share | (4.53) X | |||
| Number Of Employees | 11 | |||
| Beta | -0.32 | |||
| Market Capitalization | 4.32 B | |||
| Total Asset | 12.19 M | |||
| Retained Earnings | (121 M) | |||
| Net Asset | 12.19 M |
About Medivie Therapeutic Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medivie Therapeutic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medivie Therapeutic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medivie Therapeutic based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medivie Therapeutic. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for Medivie Stock analysis
When running Medivie Therapeutic's price analysis, check to measure Medivie Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medivie Therapeutic is operating at the current time. Most of Medivie Therapeutic's value examination focuses on studying past and present price action to predict the probability of Medivie Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medivie Therapeutic's price. Additionally, you may evaluate how the addition of Medivie Therapeutic to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets |